Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLIADEL Compared to Stereotactic Radiosurgery in Subjects With Metastatic Brain Disease
NCT04222062Phase 2Recruiting
- Sponsor
- University of Nebraska
- Start
- Nov 2020
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in brain tumor comparing Standard of Care Arm with GLIADEL Arm (2 arms). Primary endpoint: Efficacy of GLIADEL compared to Stereotactic Radiosurgery (SRS) at 12 months. Started Nov 2020; status: recruiting.
02
Drugs
carmustine
03
Conditions
brain tumor
Beyond the preview
Go deeper on NCT04222062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04222062.